India’s pharmaceutical manufacturing industry is one of the largest in the world. Thus, it plays an essential role in global healthcare. India is recognized for its cost-effective, high-quality medications, which account for more than 20% of the global generic drug market.
Third-party manufacturing is an essential part of this industry, allowing companies to produce medicines without owning manufacturing facilities. This model helps businesses expand their product range, reduce costs, and ensure compliance with quality standards.
As the world’s largest producer of pharmaceuticals, India continues to promote healthcare innovation and affordability.
What is Third-Party Pharma Manufacturing?
Third-party pharma manufacturing is a process where a pharmaceutical company (brand owner) outsources the production of medicines to specialized manufacturers. These manufacturers produce drugs under the brand name of the outsourcing company, ensuring high-quality standards and regulatory compliance.
Role of Third-Party Manufacturers
They handle everything from sourcing raw materials to manufacturing, packaging, and quality control, allowing brand owners to focus on marketing and distribution. This model helps companies expand their product range while maintaining quality and affordability for consumers.
Benefits Third-Party pharma Manufacturers
- Cost-Effective: Reduces production costs and investment in infrastructure.
- High Quality: Ensures compliance with industry standards and regulations.
- Efficiency: Faster production and market availability.
Why India is a Hub for Third-Party Pharma Manufacturing?
India is the world’s third-largest pharmaceutical producer, making it a key player in third-party pharma manufacturing. The country offers cost advantages due to affordable labour, easily available raw materials, and efficient production processes.
India also has a highly skilled workforce and adheres to international quality standards, with many manufacturers being WHO-GMP certified. Additionally, India’s large domestic market and strong global export capacity make it an ideal location for pharma outsourcing. These factors contribute to India’s reputation as a reliable and cost-effective hub for third-party pharmaceutical manufacturing.
Key Players in Third-Party Pharma Manufacturing in India
India’s pharmaceutical landscape is bolstered by several key players specializing in third-party manufacturing, offering a range of services from active pharmaceutical ingredients (APIs) to complex formulations.
1. Cadila Healthcare Ltd.
Cadila Healthcare Ltd. has established a significant global presence, exporting to over 100 countries. The company’s diverse portfolio encompasses APIs, formulations, and vaccines, underscoring its comprehensive manufacturing capabilities.
2. Iscon Life Sciences pvt Ltd
Iscon Life Sciences is renowned for its unwavering commitment to quality and customer service. With a robust infrastructure, the company provides third party pharma manufacturing services across various therapeutic segments, ensuring compliance with international standards.
3. Sun Pharmaceutical Industries
Sun Pharmaceutical Industries stands as one of India’s largest pharma entities, with a revenue of ₹3,966 crore in FY24. The company boasts a vast export network, delivering a wide array of products, including generics and speciality formulations, to numerous countries.
4. Alkem Laboratories
Alkem Laboratories has made its mark with a strong reputation for quality and innovation. The company offers third-party manufacturing services, producing a diverse range of pharmaceutical products that cater to both domestic and international markets.
5. Eskag Pharma Pvt. Ltd.
Eskag Pharma Pvt. Ltd. focuses on contract manufacturing with a stringent emphasis on quality control. Their operations span multiple therapeutic areas, including women’s healthcare, gastrointestinal therapy, and chronic kidney disease. Eskag Pharma’s facilities are WHO-GMP certified, reflecting their commitment to maintaining high manufacturing standards.
Collectively, these companies contribute significantly to India’s prominence in the global pharmaceutical manufacturing sector, offering scalable operations, extensive capacities, and serving a diverse international clientele.
Also Looking for PCD Pharma Franchise in UP
Key Statistics to Consider:
- Market share: India’s pharma exports reached $27.9 billion in FY24, a 9.67% increase.
- WHO-GMP certified plants: 2,006 plants as of 2019, with Gujarat leading at 684.
- Third-party manufacturers: Over 1,000 companies operate in India.
- Employment: The sector employs millions across research, manufacturing, and sales.
Final Thoughts
Choosing the right pharmaceutical manufacturing partner is essential for ensuring product quality, regulatory compliance, and operational efficiency.
Thorough research, collaboration, and a strong partnership with a trusted manufacturer can significantly impact your business’s success. Prioritize quality and reliability for sustainable growth and long-term success.